Early‐onset hereditary prostate cancer is not associated with specific clinical and biological features
A Valeri, R Azzouzi, E Drelon, A Delannoy… - The …, 2000 - Wiley Online Library
BACKGROUND Familial prostate cancer (CaP) accounts for 15–20% of all CaP, and
hereditary CaP for 5–10% of patients. Few data are available concerning their clinical and …
hereditary CaP for 5–10% of patients. Few data are available concerning their clinical and …
[引用][C] Early-onset hereditary prostate cancer is not associated with specific clinical and biological features
A VALERI, R AZZOUZI, E DRELON… - The …, 2000 - pascal-francis.inist.fr
Early-onset hereditary prostate cancer is not associated with specific clinical and biological
features CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic Databases …
features CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic Databases …
Early-onset hereditary prostate cancer is not associated with specific clinical and biological features.
A Valeri, R Azzouzi, E Drelon, A Delannoy, P Mangin… - The Prostate, 2000 - europepmc.org
Background Familial prostate cancer (CaP) accounts for 15-20% of all CaP, and hereditary
CaP for 5-10% of patients. Few data are available concerning their clinical and biological …
CaP for 5-10% of patients. Few data are available concerning their clinical and biological …
[PDF][PDF] Early-Onset Hereditary Prostate Cancer Is Not Associated With Specific Clinical and Biological Features
A Valeri, R Azzouzi, E Drelon, A Delannoy, P Mangin… - The Prostate, 2000 - academia.edu
BACKGROUND. Familial prostate cancer (CaP) accounts for 15–20% of all CaP, and
hereditary CaP for 5–10% of patients. Few data are available concerning their clinical and …
hereditary CaP for 5–10% of patients. Few data are available concerning their clinical and …
Early-onset hereditary prostate cancer is not associated with specific clinical and biological features
A Valeri, R Azzouzi, E Drelon, A Delannoy… - The …, 2000 - pubmed.ncbi.nlm.nih.gov
Background Familial prostate cancer (CaP) accounts for 15-20% of all CaP, and hereditary
CaP for 5-10% of patients. Few data are available concerning their clinical and biological …
CaP for 5-10% of patients. Few data are available concerning their clinical and biological …